Developmental dysplasia of the hip (DDH) is commonly addressed through surgical intervention, usually performed in a specialized tertiary care facility. The purpose of this study was to evaluate the surgical outcomes in patients with DDH who had open reduction alone or in conjunction with bone surgery at our facility. We retrospectively reviewed the medical records of patients with DDH, categorizing them into two groups: Group OR underwent open reduction (OR) alone, and group ORBO underwent OR in conjunction with femoral or pelvic osteotomies. The modified McKay classification was used to evaluate clinical outcomes, and the Severin classification was used to evaluate radiological outcomes. Avascular necrosis and other postoperative issues were observed. Our cohort consisted of 66 patients (76 hips), with a mean age at surgery of 1.8±2.6 and a follow-up period ranging from one to three years. Clinically, 48 out of 66 patients achieved satisfactory outcomes, and radiologically, 47 patients were classified as satisfactory. Although there was no statistically significant difference in the radiological outcome (P=0.85), more patients in the OR group than in the ORBO group (P=0.05) had better outcomes. Avascular necrosis (AVN) was observed in 23 hips (34.8%), with Grade I AVN being the most prevalent in 19 hips that underwent OR with bone surgery (63.2%). The occurrence of AVN was associated with poorer clinical and radiological outcomes (P=0.05). Overall, the DDH operation at our center had positive outcomes. The OR group showed better clinical outcomes despite similar radiological findings and AVN rates compared to the OR with bone surgery group. The presence of AVN was linked to poor clinical and radiological outcomes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10994604 | PMC |
http://dx.doi.org/10.25122/jml-2023-0212 | DOI Listing |
Swiss Med Wkly
January 2025
Department of Plastic, Reconstructive and Aesthetic Surgery, Ospedale Regionale di Lugano, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland.
Background: Patients with symptomatic breast hypertrophy typically suffer from chronic back pain, recurrent skin irritation at the inframammary fold and/or low self-esteem resulting in impaired quality of life. Reduction mammaplasty has been shown to effectively treat symptomatic breast hypertrophy with high patient satisfaction. Despite the obvious benefits, reimbursement requests for reduction mammaplasty are initially often refused by the patient's health insurance company, thereby frequently resulting in additional examinations and eventually extra expenses.
View Article and Find Full Text PDFWorld J Gastroenterol
January 2025
Department of Radiology, Nanfang Hospital, Southern Medical University, Guangzhou 510151, Guangdong Province, China.
Background: Transjugular intrahepatic portosystemic shunt (TIPS) is an effective intervention for managing complications of portal hypertension, particularly acute variceal bleeding (AVB). While effective in reducing portal pressure and preventing rebleeding, TIPS is associated with a considerable risk of overt hepatic encephalopathy (OHE), a complication that significantly elevates mortality rates.
Aim: To develop a machine learning (ML) model to predict OHE occurrence post-TIPS in patients with AVB using a 5-year dataset.
Objective: Transrectal (TR) prostate biopsy is being increasingly abandoned in favour of a transperineal (TP) approach as well as a targeted biopsy only of the index lesion(s). It remains underreported how these changes could impact concordance at final pathology. We aimed to evaluate the impact of transitioning from standard transrectal (sTR) to cognitive targeted transperineal (cog-tTP) biopsy on final pathology including concordance and upgrading.
View Article and Find Full Text PDFIJID Reg
March 2025
IHU-Méditerranée Infection, Marseille, France.
Objectives: Analysis of current 2023-2024 (Mp) infection characteristics in adults.
Methods: A retrospective case series analysis was performed on polymerase chain reaction-positive adult patients admitted to the University Hospital of Marseille from April 2017 to June 2024. Clinical presentations, treatments, and outcomes were assessed.
Oncol Lett
March 2025
Department of Radiation Oncology, Hacettepe University Faculty of Medicine, Ankara, Ankara 06230, Turkey.
Glioblastoma multiforme (GBM) is a tumor with a high refractory rate to immunotherapy and a low tumor mutational burden phenotype, leading to limited immunogenic neoantigens. The present study aimed to investigate the sequential use of immunotherapy and bevacizumab in patients with GBM, exploring the clinical outcomes and potential complications. Patients received various combinations of immunotherapy and bevacizumab after standard treatment, including surgery, radiotherapy and temozolomide.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!